Leclanche SA Reports Revenue Results for the First Half of 2016; Provides Revenue Guidance for the Year 2016; Provides EBITDA Guidance for the Year 2018
Full year 2016, revenues will be approximately CHF 28 million, which is an increase of 55% over 2015. The difference between this and the 100% planned uplift under the Growth Plan is largely attributable to a delay in financial closing of the IESO Canadian Project implying a delay in shipping of goods and a fire at the company's cell manufacturing facility in Germany.
The company aims to achieve EBITDA breakeven in 2018.